Sign in

CIK 0001658551

  • Non-accelerated filer
  • Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464600503
Phone
+1 617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
  1. 4 Planned sale Chief Medical Officer sold 49,579 shares at an average $30.54 ($1,513,942)
  2. 4 Open-market sale 10% owner sold 29,048 shares at $30.45 ($884,512)
  3. 4 Open-market sale 10% owner sold 160,964 shares at an average $30.42 ($4,896,561)
  4. 4/A Open-market sale Chief Financial Officer sold 32,500 shares at an average $31.89 ($1,036,459)
  5. 4/A Open-market sale Chief Medical Officer sold 54,627 shares at an average $31.87 ($1,741,200)
  6. 4 Open-market sale 10% owner sold 63,448 shares at an average $31.91 ($2,024,494)
  7. 4 Open-market sale Co-Chief Executive Officer sold 100,000 shares at an average $31.86 ($3,186,236)
  8. 4 Grant or award Chief Commercial Officer acquired 18,333 shares (grant or award)
  9. 4 Open-market sale Director sold 35,000 shares at an average $31.89 ($1,116,072)
  10. 4 Open-market sale Chief Medical Officer sold 54,627 shares at an average $31.87 ($1,741,200)
  11. 4 Grant or award Chief Legal Officer acquired 18,333 shares (grant or award)
  12. 4 Open-market buy Director bought 1,000 shares at $31.99 ($31,990)
  13. 4 Open-market sale Co-Chief Executive Officer sold 100,000 shares at an average $31.86 ($3,186,336)
  14. 4 Open-market sale Chief Financial Officer sold 32,500 shares at an average $31.89 ($1,036,459)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale 10% owner sold 9,122 shares at $32.55 ($296,921)
  17. 4 Open-market sale 10% owner sold 220,714 shares at an average $33.68 ($7,433,459)
  18. 4 Open-market sale 10% owner sold 50,000 shares at $33.75 ($1,687,500)
  19. 4 Open-market sale Chief Legal Officer sold 3,586 shares at $34.49 ($123,672)
  20. 4 Open-market sale 10% owner sold 50,000 shares at an average $34.73 ($1,736,352)

Page 8 of 11 · 207 filings